
Teleflex Incorporated
Teleflex Incorporated (TFX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TFX · as of Jun 8, 2026
Key Statistics
Explore Teleflex Incorporated Data
tfx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 29 · Buy rate: 51.7%
The TFX analyst consensus is Buy, based on ratings from 29 Wall Street analysts over the past 3 months. The average 12-month price target is $143.29, representing +7.62% upside from the current price of $133.15.
Competitors & Peers
tfx competitorsStock Performance
Full HistoryAbout Teleflex Incorporated
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It…
what is teleflex incorporated · tfx stock overview · teleflex incorporated company profile · who is teleflex incorporated ceo · tfx NYSE · teleflex incorporated headquarters · teleflex incorporated business segments
About Stock Overview & Key Data
Teleflex Incorporated (TFX) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NYSE since Mar 17, 1980. As of the latest trading session, TFX stock price is $133.15, with a market capitalization of $5.9B. The stock has returned +8.02% over the past 12 months and +9.11% year-to-date.
According to 29 Wall Street analysts, the consensus rating for Teleflex Incorporated stock is Buy, with an average 12-month price target of $143.29. In fiscal year 2025, Teleflex Incorporated reported revenue of $2.0B and net income of -$905.6M. For detailed data — including Teleflex Incorporated revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Teleflex Incorporated (TFX) stock price is $133.15. The stock is traded on NYSE under the ticker symbol TFX. The 52-week range is $100.18 – $139.67.